Stock Movers: CRWV, TSMC, RKLB (Podcast)

CoreWeave shares continued to slide as its debt weakened: credit-default swaps priced in a more than 50% chance of default within five years, while its bonds yielded 15%. TSMC projected December-quarter sales of up to $54.3 billion, above expectations, but its outlook did not stem a global technology-stock rout. Rocket Lab fell after delaying Neutron’s first flight to 2027; CEO Peter Beck said the company would not accept unnecessary risk to meet the schedule.

Analysis

CRWV’s key risk is a financing feedback loop, not simply a higher cost of debt: if funding becomes less available or more expensive, investors may question the pace of capacity expansion; that could weaken customer confidence and make future financing harder. This is a potential equity-dilution and execution risk, but the credit signal alone does not establish a default path. Over the next 1–3 months, track bond/CDS stabilization, financing disclosures, and evidence that customer commitments support planned capacity. A sustained credit deterioration would invalidate any dip-buy thesis.

TSM’s outlook supports earnings visibility, but may not insulate the stock while investors are repricing technology-sector risk. The near-term question is whether broad risk aversion becomes a cut to AI-related capex expectations. Over 6–18 months, sustained demand would favor TSM’s position against alternative foundry capacity; watch reported sales, margins, and customer capex commentary rather than guidance alone. A reversal in those indicators would undermine the constructive view.

RKLB’s schedule slip raises the risk that Neutron’s commercial contribution arrives later than investors expect. Conversely, avoiding a rushed first flight may reduce costly failure risk. The market may be underweighting the value of execution quality, but repeated milestone slippage or deterioration in funding and contract indicators would make the delay more concerning. Near-term sentiment risk is clearer than the eventual economics, which remain unverified.

Key Decisions for Investors

• CRWV: Avoid adding to long exposure while credit remains under pressure. Consider a defined-risk bearish position only if bond/CDS weakness persists and equity liquidity permits; cover or reassess if credit stabilizes and the company demonstrates financing access. Verify maturities, liquidity, and customer concentration before sizing.
• TSM: Prefer staged exposure on broad-market weakness over chasing the guidance reaction. Reassess if monthly sales, margins, or customer capex signals weaken; broad tech selling alone is not confirmation of deteriorating fundamentals.
• RKLB: Keep exposure small or wait for a credible Neutron milestone before adding. Track development schedule, cash runway, and contract/backlog updates; the thesis improves if milestones hold and worsens with further delays or funding pressure.
• No clean pair trade is established by these developments alone: CRWV credit risk, TSM foundry demand, and RKLB launch execution have different drivers. Revisit relative-value trades only after checking valuation, positioning, and updated company disclosures.